The Effect of the Novel Macrolide Glasmacinal (EP395) on Allergen-Induced Eosinophil Infiltration into the Lung

Glasmacinal attenuated eosinophilic airway inflammation in two preclinical models, supporting its potential as a novel therapy for reducing exacerbations in COPD and asthma.